Teligent Announces Agreements to Exchange Approximately $65 million of its 3.75% Senior Convertible Notes Due 2019 for 4.75% Senior Convertible Notes Due 2023 Pharmaceutical Investing
Onconova Therapeutics Announces Pricing of $25.0 Million Upsized Underwritten Public Offering Biotech Investing
AIT Therapeutics Receives Patent Allowance for Delivery of Inhaled Nitric Oxide at Concentrations of at Least 160ppm for Treatment of Bronchiolitis in Infants Medical Device Investing
Lexaria Announces LOI with Hill Street Beverage Co. for Cannabis Infused Alcohol-Free Beer and Wine Biotech Investing
Corvus Pharmaceuticals Announces Initiation of Phase 1/1b Clinical Trial of Investigational Anti-CD73 Antibody, CPI-006 Pharmaceutical Investing
Achaogen Wins CARB-X Funding Award to Advance Development of Novel Aminoglycoside to Fight Highly Biotech Investing
Krystal Biotech Announces FDA Clearance of IND on KB103 to Begin Enrolling Patients for the Treatment of Dystrophic Epidermolysis Bullosa Genetics Investing
Axsome Therapeutics Announces Positive Outcome of Interim Analysis of STRIDE-1 Phase 3 Trial of AXS-05 Pharmaceutical Investing
